Filing Flows › Anika Therapeutics (ANIK) › OEM Channel revenue
Anika Therapeutics (ANIK) OEM Channel revenue by quarter
Anika Therapeutics' OEM Channel revenue was $16.6M in Q3 2026 (third quarter 2026), -11% from Q2 2026. Over the last 7 quarters it ranged from $14.9M (Q1 2025) to $18.7M (Q2 2026).
| Quarter | OEM Channel revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $16.6M | -11% | +5% |
| Q2 2026 | $18.7M | +10% | +14% |
| Q1 2026 | $17.0M | -2% | +14% |
| Q4 2025 | $17.3M | +9% | — |
| Q3 2025 | $15.8M | -3% | — |
| Q2 2025 | $16.3M | +10% | — |
| Q1 2025 | $14.9M | — | — |
Q3 2026 at a glance
Anika Therapeutics, Q3 2026: revenue $30.6M (+10% year over year), operating margin -2.3%, net loss $311K, operating cash flow $8.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Anika Therapeutics' OEM Channel revenue?
Anika Therapeutics' OEM Channel revenue was $16.6M in Q3 2026 (third quarter 2026), -11% from Q2 2026.
How has Anika Therapeutics' OEM Channel revenue changed?
Over the last 7 quarters it ranged from $14.9M (Q1 2025) to $18.7M (Q2 2026).